Antibodies against a pancreatic specific biomarker Anti-hFXYD2γa are specific and sensitive monoclonal and polyclonal antibodies allowing early identification of human pancreatic β-cell and the follow up of therapies for diabetes.

AMP 2011 Annual Meeting, Grapevine - November 17-19, 2011 Eurogentec will be exhibiting at the Association for Molecular Pathology (AMP) 2011 Annual Meeting, November 17-19, 2011, held in the Gaylord Texan Hotel & Convention Center, Grapevine, Texas, USA. Our booth # is 301.

Biologics facility completes US FDA Inspection Eurogentec announced today that it has successfully completed a US FDA Pre-Approval Inspection (PAI) and that it will start commercial manufacturing of a biologic for the USA market.